Cybin (CYBN.NEO) to target alcoholism in upcoming CYB003 clinical studies

Agriculture, Mushrooms, News Summary, Psychedelics, Series

Related Posts

Top 5 stock gainers and losers: GOOD.V, GEN.V, NRX.V

Top 5 stock gainers and losers: OOR.V, WEED.TO, CYBN.NE

Cybin (CYBN.NEO) approved for first-in-human dosing

MYND Life Sciences (MYND.C) provides unorthodox route to better mental health

Psychedelics’ growing global map of legalization – another sector roundup

From Leary’s lunacy to a legitimate lab – psychedelics sector in review

More on CYBN.NE

Top 5 stock gainers and losers: GOOD.V, GEN.V, NRX.V

Top 5 stock gainers and losers: OOR.V, WEED.TO, CYBN.NE

Cybin (CYBN.NEO) approved for first-in-human dosing

MYND Life Sciences (MYND.C) provides unorthodox route to better mental health

Psychedelics’ growing global map of legalization – another sector roundup

From Leary’s lunacy to a legitimate lab – psychedelics sector in review

Leave a Reply Cancel reply